Literature DB >> 11056491

Side effects of endocrine treatment and their mechanisms: castration, antiandrogens, and estrogens.

P O Hedlund1.   

Abstract

Endocrine treatment of prostate cancer can be performed under several different regimes. They all have side effects which in different ways influence quality of life and the patient's general health. This paper is a survey of the most important early side effects of the different modes of endocrine treatment, their etiology, and possible ways to avoid or treat them. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056491     DOI: 10.1002/1097-0045(2000)45:10+<32::aid-pros7>3.0.co;2-v

Source DB:  PubMed          Journal:  Prostate Suppl        ISSN: 1050-5881


  6 in total

1.  Adverse events associated with hormonal therapy for prostate cancer.

Authors:  Ravi J Kumar; Al Barqawi; E David Crawford
Journal:  Rev Urol       Date:  2005

Review 2.  Health-related quality-of-life assessments in patients with advanced cancer of the prostate.

Authors:  Jan Adolfsson
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 3.  Preventing and treating the complications of hormone therapy.

Authors:  Ravi J Kumar; Al Barqawi; E David Crawford
Journal:  Curr Urol Rep       Date:  2005-05       Impact factor: 2.862

4.  Subcapsular orchiectomy in the primary therapy of patients with bone metastasis in advanced prostate cancer: an anachronistic intervention?

Authors:  Oleg Rud; Julia Peter; Reza Kheyri; Christian Gilfrich; Ali M Ahmed; Wieland Boeckmann; Paul G Fabricius; Matthias May
Journal:  Adv Urol       Date:  2011-09-14

5.  Male gynecomastia and risk for malignant tumours--a cohort study.

Authors:  H Olsson; A Bladstrom; P Alm
Journal:  BMC Cancer       Date:  2002-10-16       Impact factor: 4.430

6.  Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.

Authors:  Anna Tesei; Carlo Leonetti; Marzia Di Donato; Elisa Gabucci; Manuela Porru; Greta Varchi; Andrea Guerrini; Dino Amadori; Chiara Arienti; Sara Pignatta; Giulia Paganelli; Michele Caraglia; Gabriella Castoria; Wainer Zoli
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.